Related Experiment Videos
Borderline systemic lupus erythematosus (SLE): a separate entity or a forerunner to SLE?
1Department of Internal Medicine, Mafraq Hospital, Abu Dhabi, United Arab Emirates. haideralattia@hotmail.com
International Journal of Dermatology
|May 3, 2006
Summary
Borderline systemic lupus erythematosus (SLE) shares features with classic SLE but is milder and may represent an early stage. Further follow-up is needed to confirm if it precedes full SLE development.
Area of Science:
- Rheumatology
- Immunology
- Internal Medicine
Background:
- Systemic lupus erythematosus (SLE) is a chronic autoimmune disease with diverse clinical manifestations.
- Distinguishing early or milder forms of SLE from other conditions is crucial for timely diagnosis and management.
Purpose of the Study:
- To compare patients with borderline SLE to those with classic SLE.
- To determine if borderline SLE is a distinct entity or an early manifestation of SLE.
Main Methods:
- Retrospective analysis of 71 patients' clinical data over 12 years in Abu Dhabi.
- Evaluation of criterial and non-criterial SLE features and laboratory tests.
Main Results:
- 15 patients had borderline SLE (less than four classification criteria) versus 56 with classic SLE.
- Borderline SLE patients had shorter disease duration, lacked major organ involvement and other mucocutaneous manifestations.
- Borderline SLE showed shared features like arthropathy and serositis, with a distinct autoantibody profile (lower ANF, anti-dsDNA) and antiphospholipid syndrome.
Conclusions:
- Borderline SLE is milder than classic SLE but shares many non-criterial features.
- Clinical heterogeneity and autoantibody profiles suggest borderline SLE may be a forerunner to classic SLE.
- Longer follow-up is necessary to ascertain the long-term outcome of borderline SLE patients.